<DOC>
	<DOCNO>NCT02083575</DOCNO>
	<brief_summary>role Vit C Augment iron chelation DFP DFX thalassemic patient .</brief_summary>
	<brief_title>Role Vitamin C Augment Iron Chelation With DFP DFX</brief_title>
	<detailed_description>ass safety efficacy Vit C Augment iron chelation DFP DFX thalassemic patient .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Deferiprone</mesh_term>
	<mesh_term>Chelating Agents</mesh_term>
	<criteria>• Subjects overload secondary thalassemia major • HIV positive active HCV . A history serious immunologic hypersensitivity medication anaphylaxis angioedema . Participation previous investigational drug study within 30 day precede screening . A woman childbearing potential must negative serum pregnancy test screening . She must use medically acceptable form birth control study month afterwards pregnant breastfeeding . An inability adhere designate procedure restriction protocol .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>vitamin c</keyword>
	<keyword>thalassemia major</keyword>
	<keyword>iron chelation</keyword>
</DOC>